Editorial comment.
Lotan
Yair
Y
D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017115:Catheter Ablation; D018450:Disease Progression; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
D000970:Antineoplastic Agents